Shin Yamane Selected Research

Clinical Deterioration

6/2020	One-year outcome of combination therapy with intravitreal anti-vascular endothelial growth factor and photodynamic therapy in patients with pachychoroid neovasculopathy.
9/2016	Comparison of Time to Retreatment and Visual Function Between Ranibizumab and Aflibercept in Age-Related Macular Degeneration.
5/2015	Long-term outcome of intravitreal pegaptanib sodium as maintenance therapy in Japanese patients with neovascular age-related macular degeneration.
7/2014	Long-term results of intravitreal ranibizumab for the treatment of retinal angiomatous proliferation and utility of an advanced RPE analysis performed using spectral-domain optical coherence tomography.
5/2013	Variable response of vascularized pigment epithelial detachments to ranibizumab based on lesion subtypes, including polypoidal choroidal vasculopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shin Yamane Research Topics

Disease

7	Polypoidal Choroidal Vasculopathy 01/2020 - 05/2013
7	Macular Degeneration (Age-Related Maculopathy) 11/2018 - 05/2013
5	Clinical Deterioration 06/2020 - 05/2013
4	Polyps 01/2020 - 11/2014
4	Epiretinal Membrane (Epiretinal Membranes) 04/2013 - 12/2010
3	Edema (Dropsy) 09/2016 - 05/2010
3	Wounds and Injuries (Trauma) 01/2014 - 04/2011
2	Open-Angle Glaucoma (Glaucoma, Open Angle) 10/2017 - 02/2017
2	Glaucoma 10/2017 - 02/2017
2	Retinal Vein Occlusion 01/2015 - 06/2013
2	Hemorrhage 01/2015 - 11/2014
2	Choroidal Neovascularization 09/2014 - 05/2010
2	Retinal Perforations 04/2013 - 01/2012
2	Retinal Detachment (Retinal Detachments) 01/2011 - 09/2010
1	Myopia 01/2020
1	Inflammation (Inflammations) 01/2019
1	Eye Diseases (Eye Disease) 01/2019
1	Fibrosis (Cirrhosis) 11/2018
1	Pterygium 01/2018
1	Retinal Artery Occlusion 01/2018
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2017
1	Neovascular Glaucoma 03/2016
1	Macular Edema 01/2015
1	Flushing 06/2013
1	Thrombosis (Thrombus) 06/2013
1	Choroidal Effusions 06/2012
1	Cysts 07/2011
1	Central Serous Chorioretinopathy 01/2011
1	Neoplasm Metastasis (Metastasis) 09/2010
1	Atrophy 09/2010
1	Adenocarcinoma 09/2010
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2010
1	Blindness (Hysterical Blindness) 03/2010
1	Optic Neuritis (Retrobulbar Neuritis) 03/2010

Drug/Important Bio-Agent (IBA)

6	afliberceptIBA 01/2020 - 11/2014
5	Ranibizumab (Lucentis)FDA Link 01/2020 - 05/2013
4	Retinaldehyde (Retinal)IBA 01/2018 - 07/2011
3	N-acetyltryptophanamide (NATA)IBA 10/2018 - 01/2014
3	Bevacizumab (Avastin)FDA Link 03/2016 - 05/2010
2	K-115IBA 10/2017 - 02/2017
2	rho-Associated KinasesIBA 10/2017 - 02/2017
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 08/2016 - 11/2014
2	Retinal Pigments (Pigments, Visual)IBA 09/2014 - 09/2010
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2020
1	PolyphenolsIBA 01/2019
1	Carotenoids (Carotene)IBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2018
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 01/2018
1	Pharmaceutical PreparationsIBA 02/2017
1	pegaptanib (Macugen)FDA Link 05/2015
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2015
1	FibrinIBA 11/2014
1	Gefitinib (Iressa)FDA Link 09/2010
1	SteroidsIBA 03/2010

Therapy/Procedure

9	Vitrectomy 01/2020 - 09/2010
5	Retreatment 06/2020 - 05/2010
5	Intravitreal Injections 10/2018 - 05/2010
5	Therapeutics 10/2017 - 03/2010
4	Injections 01/2020 - 08/2016
2	Sutures (Suture) 01/2018 - 01/2014
1	Photochemotherapy (Photodynamic Therapy) 01/2020
1	Trabeculectomy (Trabeculoplasty) 03/2016
1	Operative Surgical Procedures 01/2015
1	Traction 01/2012
1	Surgical Instruments (Clip) 01/2012